The clinical and prognostic significance of CD14+HLA-DR−/low myeloid-derived suppressor cells in hepatocellular carcinoma patients receiving radiotherapy
Crossref DOI link: https://doi.org/10.1007/s13277-016-4916-2
Published Online: 2016-02-05
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Dong
An, Guangyu
Xie, Shengzhi
Yao, Yajuan
Feng, Guosheng
Funding for this research was provided by:
Beijing Natural Science Foundation (7133253)
Text and Data Mining valid from 2016-02-05